M&G Alternatives Investment Management Ltd 13D and 13G filings for Barinthus Biotherapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-01-19 08:27 am Unchanged |
2022-01-19 | 13G | Barinthus Biotherapeutics plc BRNS |
M&G Alternatives Investment Management Ltd | 4,108,752 11.970% |
0 (Unchanged) |
Filing |
2021-11-05 1:33 pm Purchase |
2021-04-29 | 13G | Barinthus Biotherapeutics plc BRNS |
M&G Alternatives Investment Management Ltd | 4,108,752 11.970% |
4,108,752![]() (New Position) |
Filing |